CH542232A - Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate - Google Patents

Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate

Info

Publication number
CH542232A
CH542232A CH1476972A CH1476972A CH542232A CH 542232 A CH542232 A CH 542232A CH 1476972 A CH1476972 A CH 1476972A CH 1476972 A CH1476972 A CH 1476972A CH 542232 A CH542232 A CH 542232A
Authority
CH
Switzerland
Prior art keywords
preparation
new
oxadiazole derivatives
oxadiazole
derivatives
Prior art date
Application number
CH1476972A
Other languages
German (de)
English (en)
Inventor
Kalman Dr Harsanyi
Jozsef Dipl Ing Reiter
Dezso Dipl Ing Korbonits
Csaba Dipl Ing Gonczi
Kalman Dipl Ing Takacs
Erzsebet Dipl Ing Bako
Gyorgy Dr Med Leszkovszky
Tardos Laszlo
Vertesy Csaba
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of CH542232A publication Critical patent/CH542232A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
CH1476972A 1968-04-26 1969-04-24 Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate CH542232A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI000796 1968-04-26

Publications (1)

Publication Number Publication Date
CH542232A true CH542232A (de) 1973-11-15

Family

ID=10994349

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1476972A CH542232A (de) 1968-04-26 1969-04-24 Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate
CH627569A CH540925A (de) 1968-04-26 1969-04-24 Verfahren zur Herstellung von neuen 1,2,4-Oxadiazol-Derivaten

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH627569A CH540925A (de) 1968-04-26 1969-04-24 Verfahren zur Herstellung von neuen 1,2,4-Oxadiazol-Derivaten

Country Status (15)

Country Link
US (1) US3647809A (enExample)
JP (1) JPS4824394B1 (enExample)
AT (2) AT292728B (enExample)
BE (1) BE732131A (enExample)
BR (1) BR6908381D0 (enExample)
CA (1) CA954858A (enExample)
CH (2) CH542232A (enExample)
DE (1) DE1920037A1 (enExample)
FR (1) FR2007529B1 (enExample)
GB (1) GB1271302A (enExample)
IL (1) IL31990A (enExample)
NL (1) NL6906401A (enExample)
NO (1) NO124253B (enExample)
PL (1) PL79435B1 (enExample)
SE (1) SE368576B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853893A (en) * 1973-04-02 1974-12-10 Squibb & Sons Inc Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
HU177086B (en) * 1975-06-09 1981-07-28 Eszakmagyar Vegyimuevek Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
ATE307129T1 (de) * 1999-08-19 2005-11-15 Nps Pharma Inc Heteropolycyclische verbindungen und ihre verwendung als antagonisten von metabotropen glutamatrezeptoren
EP1582519A3 (en) * 1999-08-19 2005-12-21 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
PL369598A1 (en) * 2001-02-21 2005-05-02 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
US7074809B2 (en) 2002-08-09 2006-07-11 Astrazeneca Ab Compounds
CA2520255C (en) * 2003-04-09 2014-07-08 Exelixis, Inc. Tie-2 modulators and methods of use
WO2004103279A2 (en) * 2003-05-15 2004-12-02 Merck & Co., Inc. 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
US20060189661A1 (en) * 2003-11-03 2006-08-24 Wagenen Bradford V Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2005060961A2 (en) * 2003-12-18 2005-07-07 Astrazeneca Ab Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
NZ547965A (en) * 2003-12-24 2009-12-24 Prosidion Ltd 1,2,4-Oxadiazole derivatives as GPCR receptor agonists
WO2005077368A2 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Treatment of gastro-esophageal reflux disease (gerd)
JP2008539195A (ja) * 2005-04-26 2008-11-13 ノイロサーチ アクティーゼルスカブ 新規のオキサジアゾール誘導体及びそれらの医学的使用
IL169855A (en) * 2005-07-25 2014-05-28 Elta Systems Ltd A system and method for locating a receiver location
SI1907382T1 (sl) 2005-07-26 2015-10-30 Bial-Portela & Ca S.A., Nitrokateholni derivati kot inhibitorji COMT
EP1845097A1 (en) * 2006-04-10 2007-10-17 Portela & Ca., S.A. Oxadiazole derivatives as COMT inhibitors
MY149853A (en) * 2006-09-07 2013-10-31 Actelion Pharmaceuticals Ltd Pyridin-4-yl derivatives as immunomodulating agents
AR062684A1 (es) * 2006-09-08 2008-11-26 Actelion Pharmaceuticals Ltd Compuestos derivados de piridin-3- ilo, composicion farmaceutica que los contiene, y uso de los mismos en la preparacion de medicamentos
ES2597705T3 (es) * 2007-01-31 2017-01-20 Bial - Portela & Ca., S.A. Derivados de nitrocatecol como inhibidores de COMT administrados con un régimen de dosificación específico
DK2125797T3 (da) * 2007-03-16 2014-02-10 Actelion Pharmaceuticals Ltd Aminopyridinderivater som s1p1/edg1-receptoragonister
HRP20110449T1 (hr) * 2007-08-17 2011-07-31 Actelion Pharmaceuticals Ltd. Derivati piridina kao modulatori receptora s1p1/edg1
EP2259777A2 (en) * 2008-02-28 2010-12-15 BIAL - Portela & Ca., S.A. Pharmaceutical composition for poorly soluble drugs
CA2714665A1 (en) * 2008-03-06 2009-09-11 Actelion Pharmaceuticals Ltd Pyridine compounds
JP5435745B2 (ja) * 2008-03-07 2014-03-05 アクテリオン ファーマシューティカルズ リミテッド 免疫調節剤としてのピリジン−２−イル誘導体
EP2276758B1 (en) 2008-03-17 2016-01-06 Bial-Portela & CA, S.A. Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,4] oxadiazol-5-yl]-3-nit robenzene-1, 2-diol
PL2291080T3 (pl) * 2008-05-14 2015-12-31 Scripps Research Inst Nowe modulatory receptorów sfingozyno-1-fosforanu
ES2754503T3 (es) 2009-02-10 2020-04-17 Monsanto Technology Llc Composiciones y procedimientos de lucha contra nematodos
AU2010231962B2 (en) * 2009-04-01 2015-05-21 Bial - Portela & Ca., S.A. Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
KR102329271B1 (ko) * 2009-04-01 2021-11-22 바이알 - 포르텔라 앤드 씨에이 에스에이 니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
KR101409131B1 (ko) 2009-07-16 2014-06-17 액테리온 파마슈티칼 리미티드 피리딘-4-일 유도체
WO2012098505A1 (en) 2011-01-19 2012-07-26 Actelion Pharmaceuticals Ltd 2-methoxy-pyridin-4-yl derivatives
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
PL2791134T3 (pl) 2011-12-13 2020-03-31 BIAL - PORTELA & Cª S.A. Związek chemiczny użyteczny jako związek pośredni do wytwarzania inhibitora katechol-o-metylotransferazy
US9232800B2 (en) * 2013-02-15 2016-01-12 Monsanto Technology Llc 3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles and compositions and methods for controlling nematode pests
RU2017120184A (ru) 2014-11-28 2018-12-28 БИАЛ - ПОРТЕЛА ЭНД Ка, С.А. Лекарства для замедления течения болезни паркинсона
EP3298008B1 (en) 2015-05-20 2019-11-20 Idorsia Pharmaceuticals Ltd Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL256329A (enExample) * 1959-09-29
US3227725A (en) * 1962-04-17 1966-01-04 Union Carbide Corp Certain 3,5-disubstituted 1,2,4-oxadiazole compounds

Also Published As

Publication number Publication date
FR2007529A1 (enExample) 1970-01-09
PL79435B1 (en) 1975-06-30
US3647809A (en) 1972-03-07
SE368576B (enExample) 1974-07-08
BE732131A (enExample) 1969-10-01
IL31990A0 (en) 1969-06-25
BR6908381D0 (pt) 1973-02-08
NO124253B (enExample) 1972-03-27
DE1920037A1 (de) 1970-11-12
CH540925A (de) 1973-08-31
GB1271302A (en) 1972-04-19
AT292728B (de) 1971-09-10
IL31990A (en) 1974-05-16
CA954858A (en) 1974-09-17
FR2007529B1 (enExample) 1973-03-16
JPS4824394B1 (enExample) 1973-07-20
AT292727B (de) 1971-09-10
NL6906401A (enExample) 1969-10-28

Similar Documents

Publication Publication Date Title
CH542232A (de) Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate
CH551411A (de) Verfahren zur herstellung neuer n-phenylindolin-derivate.
AT319971B (de) Verfahren zur Herstellung neuer geschützter 4,6-O-Alkyliden-Β-D-glucopyranosen
AT289776B (de) Verfahren zur Herstellung neuer 1-Carbamoyl-3-aroylpyrrolidine
CH516508A (de) Verfahren zur Herstellung neuer substituierter Hydroxyphenylalkylamine
AT303000B (de) Verfahren zur Herstellung neuer Triazenderivate
CH498120A (de) Verfahren zur Herstellung neuer Indenopyridinderivate
CH467798A (de) Verfahren zur Herstellung neuer 1,3-Dioxan-Derivate
CH520156A (de) Verfahren zur Herstellung neuer Perhydro-5-phenylcyclo-alkapolyen-1,4-oxazepine
AT287665B (de) Verfahren zur Herstellung von 2,2-Dimethyl-3-hydroxypropanal
CH513119A (de) Verfahren zur Herstellung neuer Halogencolchicinderivate
AT282644B (de) Verfahren zur Herstellung der neuen 1,2-Diphosphacyclopenten-(5)-on-(4)-Derivate
AT291253B (de) Verfahren zur Herstellung von neuen 1,3,4-Thiadiazolderivaten
AT305253B (de) Verfahren zur Herstellung neuer Diphenoxyacetamide
AT295515B (de) Verfahren zur Herstellung neuer 3,5-Dioxo-pyrazolidine
AT293635B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstanderivate
CH538466A (de) Verfahren zur Herstellung neuer 14,15B-Epoxycardenolide
AT281816B (de) Verfahren zur Herstellung von neuen 1,2-Benzixothiazol-Derivate
CH513131A (de) Verfahren zur Herstellung neuer Aminobenzocycloalkylnitrile
CH528513A (de) Verfahren zur Herstellung neuer substituierter Triazenopyrazole
CH511227A (de) Verfahren zur Herstellung neuer Azetidinolderivate
CH471828A (de) Verfahren zur Herstellung neuer 1,2a-Methylen-5a-androstanderivate
AT284851B (de) Verfahren zur Herstellung des neuen 4,5,6-Trichlor-2-chlorcarbonyl-pyrimidins
CH532612A (de) Verfahren zur Herstellung neuer a-Azidobenzylpenicilline
AT285619B (de) Verfahren zur Herstellung neuer substituierter 3-Amino-4-halogen-sydnonimine

Legal Events

Date Code Title Description
PL Patent ceased